Lionel Messi and Cristiano Ronaldo are potential targets for Inter-Miami, co-owner David Beckham said on Wednesday, underscoring his team's global ambition as they prepare to make their long-awaited Major League Soccer debut this weekend.
What happened
Shares of Realogy Holdings (NYSE: RLGY) shed more than 11% of their value on Wednesday, following the company's release of its fourth-quarter results.
(RTTNews) - The Malaysia stock market moved lower again on Wednesday, one session after it had ended the two-day slide in which it had fallen almost 45 points or 3 percent. The Kuala Lumpur Composite Index now rests just above the 1,490-point plateau and it may see continued sel
Gilead Sciences (NASDAQ: GILD) announced Wednesday evening that it's initiating two late-stage clinical studies to evaluate its experimental antiviral drug remdesivir in treating adults diagnosed with coronavirus disease COVID-19.
Arkansas' licensing program for medical marijuana dispensaries has come to a screeching halt -- at least for now. A legal dispute has led a judge to order a suspension of the activity by the state.
Arkansas' licensing program for medical marijuana dispensaries has come to a screeching halt -- at least for now. A legal dispute has led a judge to order a suspension of the activity by the state.
Last year, Etsy (NASDAQ: ETSY) announced a multi-year strategy to lay the foundation for long-term growth. On a basic level, this called for improving the experience for sellers with better marketing and investing in technology. Those efforts seem to be bearing fruit, as eviden
Last year, Etsy (NASDAQ: ETSY) announced a multi-year strategy to lay the foundation for long-term growth. On a basic level, this called for improving the experience for sellers with better marketing and investing in technology. Those efforts seem to be bearing fruit, as eviden
What happened
In response to the company announcing mixed fourth-quarter results and issuing weak guidance, shares of Supernus Pharmaceuticals (NASDAQ: SUPN), a biopharma focused on diseases of the central nervous system, slumped 15% on Wednesday.